Topics

Asia Deal Watch: ASLAN, Bukwang Establish Immuno-Oncology JV In Singapore

12:28 EDT 2 Oct 2019 | SCRIP

The JV to be called JAGUAHR Therapeutics will focus on the AhR pathway. Simcere acquires Chinese rights to JW’s gout...

      

Related Stories

 

Original Article: Asia Deal Watch: ASLAN, Bukwang Establish Immuno-Oncology JV In Singapore

NEXT ARTICLE

More From BioPortfolio on "Asia Deal Watch: ASLAN, Bukwang Establish Immuno-Oncology JV In Singapore"

Quick Search

Relevant Topic

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...